INTRODUCTION
Stem cells undergo discrete developmental changes throughout life but little is known about how these transitions are regulated. A particularly profound transition occurs between fetal development and adulthood, when stem cells from diverse tissues undergo changes in phenotype, function, and regulation (Molofsky et al., 2004) . This raises the possibility that transcriptional programs that maintain stem cell identity and function change between fetal and adult life.
One cardinal feature of stem cells that changes with development is self renewal. Even self-renewal mechanisms that are broadly conserved among tissues fail to be maintained across developmental time (Molofsky et al., 2004) .
Oct4 and Nanog are required for the self renewal of embryonic stem cells but not fetal or adult somatic stem cells (Nichols et al., 1998; Chambers et al., 2003; Mitsui et al., 2003) . Bmi-1 is required for the self renewal of every postnatal stem cell yet examined, including HSCs and neural stem cells, but it is not required in vivo for the self renewal of fetal stem cells in the same tissues (Lessard and Sauvageau, 2003; Molofsky et al., 2003; Park et al., 2003) . Ink4a expression cannot be detected in fetal or young adult stem cells but increases with age in stem cells from diverse tissues, reducing self renewal potential and regenerative capacity (Janzen et al., 2006; Krishnamurthy et al., 2006; Molofsky et al., 2006) . While a great deal has been learned about embryonic and adult stem cell self renewal, comparatively less is known about mechanisms that specifically maintain fetal stem cells.
Developmental changes in the properties of stem cells have been best described in hematopoiesis (Mikkola and Orkin, 2006) . Fetal HSCs differ from adult HSCs in gene expression (Phillips et al., 2000; Ivanova et al., 2002) , marker expression (Morrison et al., 1995; Kim et al., 2005) , developmental potential (Ikuta et al., 1990; Kantor et al., 1992) , self-renewal potential (Morrison et al., 1995; Harrison et al., 1997) , and regulation Hock et al., 2004a Hock et al., , 2004b . HSCs transition from fetal to adult properties 3-4 weeks after birth, when HSCs suddenly become quiescent (Bowie et al., 2006) .
It is not clear what regulates the unique properties of fetal HSCs. A number of genes including Scl (Porcher et al., 1996) , Aml-1/Runx1 (Okuda et al., 1996; Wang et al., 1996) , Lmo2 (Warren et al., 1994) , Gata-2 (Tsai et al., 1994) , cdx4 (Davidson et al., 2003) , and mixed-lineage leukemia are required embryonically for the formation of HSCs. However, with the exception of Gata-2, there is little evidence that these genes play any ongoing role in the maintenance of HSCs after formation (Mikkola and Orkin, 2006) . For example, Scl and Aml-1/ Runx1 are dispensable for the maintenance of HSCs, at least in adulthood (Mikkola et al., 2003; Ichikawa et al., 2004) . Other genes appear to regulate the maintenance of HSCs throughout fetal and adult life including Rae28 (Ohta et al., 2002; Kim et al., 2004) , Meis1 (Hisa et al., 2004; Kirito et al., 2004; Azcoitia et al., 2005) , c-myb (Mucenski et al., 1991; Sandberg et al., 2005) , and Cbp (Rebel et al., 2002) . However, to our knowledge no gene is known to regulate the maintenance of fetal but not adult HSCs. In contrast, a number of transcriptional regulators maintain adult but not fetal HSCs, including Gfi-1 (Hock et al., 2004a) , Tel/Etv6 (Hock et al., 2004b) , and Bmi-1 . This raises the question of what transcriptional regulators act downstream of Scl and Aml-1/Runx1 to regulate fetal HSC identity and maintenance prior to the onset of the adult HSC self-renewal program.
Sry-related high mobility group box (Sox) transcription factors contain a DNA-binding domain (the HMG box) and regulate stem cell identity and function in multiple tissues (Schepers et al., 2002) . Sox17 has been used as a marker of endodermal identity (Yasunaga et al., 2005) and is required for the formation and maintenance of endoderm (Hudson et al., 1997; Kanai-Azuma et al., 2002) and vascular endothelium (Matsui et al., 2006) . But Sox family members have never been implicated in the regulation of HSCs. Here we report that within the hematopoietic system Sox17 is highly restricted in its expression to fetal and neonatal HSCs and is required for the maintenance of fetal and neonatal, but not adult HSCs. Sox17 is thus a marker of fetal identity in HSCs and distinguishes their transcriptional regulation from adult HSCs.
RESULTS
In this study we reexamined previously published gene expression profiles of highly purified fetal (Kiel et al., 2005a) and adult (Kiel et al., 2005b) mouse HSCs to identify genes that were more highly expressed in fetal as compared to adult HSCs. Sox17 was clearly detected in embryonic day (E)14.5 fetal liver HSCs, but not in CD45 + fetal liver hematopoietic cells, young adult bone marrow HSCs, young adult bone marrow CD45 + cells, or old adult bone marrow HSCs ( Figure S1 ). We confirmed this by quantitative realtime RT-PCR ( Figure S1 ). We hypothesized that Sox17 regulates fetal HSC identity or function.
Generation of Sox17-Deficient Mice
To test whether Sox17 regulates fetal HSCs we generated Sox17 knockout mice. The entire coding sequence of Sox17 was replaced with the gene encoding enhanced green fluorescence protein (eGFP), in frame with the Sox17 start codon, by homologous recombination ( Figures 1A and 1B) . Two mouse lines were generated using independently targeted ES cell lines, both of which gave germline transmission of Sox17 GFP alleles. We could not detect mRNA that contained the Sox17 coding sequence in Sox17 GFP/GFP mice by RT-PCR ( Figure 1C ).
Sox17
GFP/GFP mice from both lines showed severe growth retardation relative to littermate controls by E11.5, as well as posterior patterning and body axis rotation defects ( Figure 1D ). In both lines, Sox17 GFP/GFP mice were observed in expected ratios through E12.5 but died by E13.5 ( Figure 1E ). This phenotype is consistent with that of independently targeted Sox17-deficient mice that also died embryonically with growth retardation and posterior patterning defects (Kanai-Azuma et al., 2002) .
Sox17 Deficiency Severely Reduces Fetal Hematopoiesis
In addition to recapitulating the previously described gross phenotypes associated with Sox17 deficiency, we observed a severe defect in fetal hematopoiesis that was not reported previously. Sox17 GFP/GFP mice had some blood cells and hemorrhaging but did not develop visible hematopoiesis as observed in control littermates ( Figures 1D and 2B ). This failure of hematopoiesis affected the yolk sac ( Figure 2A ) as well as the fetal liver ( Figure 2B ) as both structures were pale in Sox17 GFP/GFP mice.
Sox17
GFP/GFP mice had significantly (p < 0.05) fewer CD45 + blood cells and Ter119 + erythroid cells in both the yolk sac and whole embryo as compared to littermate controls ( Figure 2C ). Sox17 GFP/GFP mice also exhibited significantly fewer colony-forming progenitors in yolk sac and whole embryo (CFU-C) ( Figure 2D ). All types of CFU-C were similarly reduced in number (data not shown).
The fact that these defects were most severe intraembryonically suggests that Sox17 is particularly important for definitive hematopoiesis. Figure 3C ). These data demonstrate that all, or virtually all, fetal liver HSCs express Sox17.
To examine GFP expression in postnatal bone marrow HSCs, we examined Sca-1 + Lineage À c-kit + CD48 À cells from the bone marrow of 2-, 4-, and 8 week-old mice. These cells represented 0.019% ± 0 .004% of bone marrow cells at 2 weeks but fell to 0.004% ± 0.0004% of bone marrow cells by 8 weeks of age. This population contains all of the detectable HSC activity in adult bone marrow and is highly enriched for HSCs (Kiel et al., 2005b; Yilmaz et al., 2005) . While 86% ± 5% of bone marrow Sca-1 + Line-
À cells in 2-week-old mice expressed GFP, this percentage dropped to 50% ± 8% in 4-weekold mice and to undetectable levels in 8-week-old mice ( Figure 3B ). Sox17 thus continues to be expressed by neonatal, but not adult, HSCs. Some CFU-C also expressed Sox17 in the fetal liver. All cells that formed CFU-GEMM colonies (containing granulocytes, erythrocytes, macrophages, and megakaryocytes) in culture arose from GFP + fetal liver cells, as did 65% ± 2% of all colony-forming progenitors (CFU-C) from fetal liver (data not shown). By 2 weeks after birth, only 18% ± 4% of CFU-GEMM and 9% ± 3% of all CFU-C arose from GFP + bone marrow cells. We have not been able to detect GFP + bone marrow cells in adults ( Figure 3A ). Sox17 is thus expressed by fetal and neonatal HSCs as well as some downstream progenitors.
To test whether Sox17 expression is induced in proliferating adult HSCs we treated adult Sox17 GFP/+ mice with cyclophosphamide/G-CSF (Morrison et al., 1997) . Although HSCs were driven into cycle, expanded in number, and mobilized after cyclophosphamide/G-CSF treatment, GFP was not expressed by HSCs in the bone marrow or the spleen ( Figure S2 ). This indicates that Sox17 is not simply expressed by dividing HSCs and cannot be induced in adult HSCs by proliferation or mobilization.
Sox17 Is Required for the Generation or Maintenance of Fetal HSCs
To test whether Sox17 is required for HSC function during fetal development we generated E12. transplanted with all of the yolk sac, liver cells, or remaining embryo cells from a single CD45.2 + donor embryo.
The livers of Sox17 GFP/GFP embryos were so hypocellular and pale that the entire embryos were dissociated and transplanted, rather than just fetal liver. Most of the recipients that were transplanted with liver, yolk sac, or other cells from Sox17 +/+ or Sox17 GFP/+ embryos became long-term multilineage reconstituted by donor cells (Figures 3D and 3E) . In contrast, none of the recipients transplanted with cells from Sox17 GFP/GFP embryos ever became reconstituted by donor cells. Sox17 is thus required for the generation or maintenance of definitive HSCs.
Sox17 Is Required within the Hematopoietic/ Endothelial Lineages for HSCs
To test whether Sox17 is required autonomously for the generation or maintenance of HSCs we generated a floxed allele (Sox17 To test whether Sox17 was required within the hematopoietic/endothelial lineages for the generation of HSCs we conditionally deleted Sox17 in endothelial and hematopoietic progenitors using Tie2-Cre (Koni et al., 2001 ). Tie2-Cre mice express Cre recombinase in endothelial cells and HSCs during embryonic development (Schlaeger et al., 2005; Li et al., 2006) . E12. Figure 5C ). Sox17 is thus required in endothelial/hematopoietic cells for the generation or maintenance of definitive HSCs.
Sox17-Deficient Progenitors Can Differentiate Normally and Form Definitive Erythrocytes
To test whether Sox17-deficient hematopoietic progenitors were blocked in their ability to differentiate or to transition from primitive to definitive hematopoiesis, we examined the rare colonies that arose in culture from E11.5 Figures 6B-6D ). These mice also had severely reduced thymus cellularity and significantly reduced white blood cell and platelet counts (data not shown). While CFU-C were substantially depleted after Sox17 deletion, the types of colonies they formed and the appearance and composition of the colonies did not differ from control cells (data not shown). fl/GFP mice 4-5 days after pIpC treatment initially gave low levels of multilineage reconstitution, but multilineage reconstitution could no longer be detected by 6 weeks after transplantation ( Figure 6E ). In contrast, the same dose of bone marrow cells from littermate controls gave high levels of multilineage reconstitution in all recipients ( Figure 6E ). By performing PCR on genomic DNA extracted from individual CFU-GEMM or CFU-GM colonies that arose from the bone marrow of the donor mice used in these experiments we determined that 81% of early hematopoietic progenitors from the neonatal Mx-1-Cre + Sox17 fl/GFP mice had deleted Sox17 ( Figure S4 ).
The failure of Sox17-deficient bone marrow cells to longterm multilineage reconstitute wild-type recipients indicates that Sox17 is autonomously required for the maintenance of neonatal HSCs. We also tested whether fetal HSCs require Sox17 for their maintenance in a wild-type environment in a way that is independent of their ability to home to the bone marrow after transplantation. We transplanted 200,000 unfractionated fetal liver cells from E14. were donor derived in these mice 6 weeks after transplantation ( Figure S5 ). In contrast, none of seven recipient mice transplanted with Mx-1-Cre + Sox17 fl/GFP cells were stably multilineage reconstituted: only 5% ± 10% of all CD45 + cells were donor derived 6 weeks after transplantation ( Figure S5 ). Deletion of Sox17 from fetal HSCs that have already engrafted in a wild-type environment leads to a near complete loss of reconstituting potential, indicating that Sox17 is autonomously required for the maintenance of fetal HSCs.
Since Sox17 expression is extinguished in HSCs around 4 weeks after birth ( Figure 3B Figure 6C ), numbers of CFU-C in the bone marrow (Fig. 6D ), or ability of bone marrow cells to reconstitute irradiated mice ( Figure 6E ). We also treated adult Mx-1-Cre + Sox17 fl/GFP mice and littermate controls (after pIpC treatment) with cyclophosphamide/G-CSF to mobilize HSCs but again detected no effect of Sox17 deficiency on bone marrow cellularity, spleen cellularity, HSC frequency, or HSC cell cycle status ( Figure S2 ). By performing PCR on genomic DNA extracted from colonies that arose in culture from sorted Flk2
À HSCs we confirmed that 96% of the HSCs from adult Mx-1-Cre + Sox17 fl/GFP mice had deleted Sox17 ( Figure S4 ).
Sox17 is no longer required for adult HSC maintenance, proliferation, mobilization, or hematopoiesis.
Sox17 Deletion Leads to the Death of Neonatal HSCs
To further investigate the mechanism by which Sox17 deletion leads to the loss of HSCs, we examined Sca-1 + Lin- Figure 7A) ; however, Sox17 deletion did significantly (p < 0.05) increase the rate of cell death among HSCs ( Figure 7B ).
To begin to address the molecular mechanisms by which Sox17 promotes the maintenance of HSCs, we compared the expression of candidate genes by hematopoietic progenitors isolated from Sox17-deficient or control mice. We first tested whether Sox17 was required for the expression of Runx1, Scl, Gata-2, or Lmo2. However, all of these genes were expressed at approximately wild-type levels in both CD45 failed to give long-term multilineage reconstitution in irradiated CD45.1 + wild-type recipients (n = 5), in contrast to the same dose of cells from littermates or adult mice (n = 4 or 5; differences in myeloid, B, and T cell chimerism were highly statistically significant: #, p < 0.001; 6 week time point is shown). In each case, 200,000 donor bone marrow cells were competed against 200,000 recipient bone marrow cells.
embryos ( Figure S6 ). Dkk1 expression was also elevated 3.4-fold in the same population from yolk sac. Since Dkk1 is a powerful negative regulator of Wnt pathway activation (Glinka et al., 1998) À cells were dividing significantly more slowly, with only 3% ± 1% of cells in S/G2/M ( Figure 7D ). This demonstrates that the loss of Sox17 expression is associated with the acquisition of a more slowly dividing adult phenotype. Mac-1 and AA4.1 are expressed by fetal but not adult HSCs (Morrison and Weissman, 1994; Morrison et al., 1995; Phillips et al., 2000) . (Figures 7E and 7F ).
This demonstrates that the loss of Sox17 expression is associated with the acquisition of an adult surface marker phenotype by HSCs.
DISCUSSION
The discovery that Sox17 maintains fetal but not adult HSCs fills a critical void in our understanding of HSC regulation. Prior studies identified genes like Scl, Aml-1/ Runx1, Lmo2, and Gata-2 that are required for the formation of fetal HSCs (Warren et al., 1994; Okuda et al., 1996; Porcher et al., 1996; Wang et al., 1996; Mikkola et al., 2003; Ichikawa et al., 2004) , and genes like Gfi-1, Tel/ Etv6, and Bmi-1 that are required for the maintenance of adult but not fetal HSCs Hock et al., 2004a; Hock et al., 2004b) . However, we are not aware of other genes that are required to maintain fetal HSCs prior to the acquisition of adult HSC properties. Our data suggest that Sox17 acts downstream of Scl, Aml-1/Runx1, Lmo2, and Gata-2 to maintain fetal HSCs prior to the acquisition of an adult phenotype. Quantitative RT-PCR on RNA from CD45 + c-kit + hematopoietic progenitors from E11.5 Sox17-deficient embryos showed normal or slightly elevated levels of Scl, Aml-1/Runx1, Lmo2, and Gata-2 transcripts ( Figure S6 ). This demonstrates that Sox17 is not required for the expression of Scl, Aml-1/ Runx1, Lmo2, or Gata-2 in embryonic hematopoietic cells around the time that definitive HSCs are emerging. Sox17 likely acts downstream of these genes to maintain fetal HSCs after they have formed. Our data do not rule out a role for Sox17 in the formation of definitive HSCs, but there are no data that directly support such a possibility so far.
Sox17 may be required to maintain fetal and neonatal HSCs by promoting Wnt signaling. Neonatal HSCs underwent cell death within days of Sox17 deletion ( Figure 7B ), and Sox17 deletion dramatically increased Dkk1 expression in neonatal and embryonic hematopoietic progenitors ( Figure S6 ). Dkk1 negatively regulates Wnt pathway activation (Glinka et al., 1998) , suggesting that Sox17 deletion may lead to reduced Wnt signaling in HSCs. Consistent with this possibility, Sox17 can negatively regulate the expression of ß-catenin target genes in some contexts (Zorn et al., 1999; Sinner et al., 2004) . Moreover, Wnt3a-deficient mice (Takada et al., 1994) and Tcf4/Tcf1-deficient mice (Gregorieff et al., 2004 ) have posterior patterning defects that are similar to the posterior patterning defect we observed in Sox17 deficient mice (Figure 1 ). Wnt pathway activation has been implicated in the regulation of adult HSC self renewal Willert et al., 2003) , though it may not be necessary (Cobas et al., 2004) , and it is unknown whether Wnt signaling is important for fetal HSC maintenance. Additional studies will be required to test whether Sox17 promotes the maintenance of fetal/ neonatal HSCs by promoting Wnt signaling. We also do not know whether overexpression of Sox17 in adult HSCs would be sufficient to induce a fetal phenotype.
The identification of Sox17 as a critical regulator of fetal/ neonatal HSCs demonstrates that the transcriptional programs that maintain HSCs change over time. This implies that the regulation of stem cell identity may change with developmental time, perhaps in concert with functional changes. The discovery that Sox17 is autonomously required for the maintenance of fetal and neonatal but not adult HSCs identifies a new stage-specific mechanism for the maintenance of HSCs that fills a gap between previously identified mechanisms for the embryonic formation of HSCs and the maintenance of adult HSCs. , fetal liver cells and bone marrow cells were stained as previously described (Kiel et al., 2005b; Kim et al., 2006) . Whole fetal liver cells were incubated with unconjugated monoclonal antibodies to lineage markers including B220 (6B2), CD3 (KT31.1), CD5 (53-7.3), CD8 (53-6.7), Gr-1 (8C5), and Ter119 (Ter-119). Pelleted cells were resuspended in anti-rat IgG specific F(ab) 2 conjugated to phycoerythrin (PE; Jackson ImmunoResearch; West Grove, PA). Cells were then stained with directly conjugated antibodies to Mac-1 (M1/70-allophycocyanin (APC)), Sca-1 (Ly6A/E-biotin), CD48 (HM48-1-PE), and CD4 (GK1.5-PE), followed by staining with streptavidin conjugated to APC-Cy7 (PharRed; PR) (BD Biosciences; San Jose, CA). Adult whole bone marrow cells were stained in the same manner as whole fetal liver cells except that different fluorochromes were used for Mac-1 (M1/70-PE) and Sca-1 (Ly6A/E-APC), and c-kit (2B8-biotin) was also included as a marker.
To analyze the expression of GFP in E10.5 or E11.5 embryos, embryos and yolk sacs were separated carefully and digested with collagenase type I (1 mg/ml) in the presence of 10% FBS at 37 C for 1.5 hr as previously described . Isolated cells were stained with unconjugated anti-CD144 (clone 11D4.1; BD BioSciences), which was detected by anti-rat IgG-APC (Jackson ImmunoResearch), anti-CD45-biotin (clone 30-F11; eBioscience, San Diego, CA), and Ter119-PE. Cells were resuspended in 2mg/ml 7-AAD (Molecular Probes; Eugene, OR) to discriminate live from dead cells. All flow cytometry was performed on a FACSVantage SE-dual laser, three-line flow cytometer (Becton-Dickinson).
Long-Term Competitive Reconstitution Assays
Recipients in reconstitution assays were adult C57Bl/Ka-CD45.1:Thy-1.2 mice. Adult recipient mice were irradiated with an Orthovoltage x-ray source delivering approximately 300 rads/min in two doses of 550-570 rad each, delivered at least 2 hr apart. Transplanted cells were injected into the retro-orbital venous sinus of individual lethally irradiated recipients along with 200,000 recipient bone marrow cells for radioprotection. For at least 16 weeks after transplantation, blood was obtained from the tail veins of recipient mice, subjected to ammonium-chloride/potassium bicarbonate red cell lysis, and stained with directly conjugated antibodies to CD45.2 (104), B220 (6B2), Mac-1 (M1/70), CD3 (KT31.1) and Gr-1 (8C5) to monitor donor cell engraftment.
Methylcellulose Culture Cells were plated in wells of 96-well plates (Corning; Corning, NY) containing 100 ml of 1.0% MethoCult GFM3434 (Stem Cell Technologies; Vancouver, Canada). 
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